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ABSTRACT
Introduction: The prevalence of malaria in Lampung Province was increased in the last few years. One of 
the factors contributes to the increased rate is the widespread of the Plasmodium falciparum resistance to 
antimalarial drugs. Mutation on the gene encoding Pfcrt protein has been reported to be correlated with 
this resistance.
Objective: To fi nd out the frequency and distribution of the pfcrt gene polymorphism among Plasmodium 
falciparum in malaria patients in endemic area at Bandar Lampung and Lampung Selatan, Lampung 
Province.
Methods: Blood samples were collected from malaria falciparum patients in Bandar Lampung and 
Lampung Selatan by active and passive case detections. Two to three mL of venous blood were collected in 
tubes with EDTA, and kept in the temperature of -200C before DNA extraction. DNA from each sample was 
extracted using Guanidine isothiocyanate and Chelex 100 methods. Genes encoding Pfcrt protein were 
amplifi ed by Nested PCR using TCRP and TCRD primers. The polymorphism of the pfcrt gene was identifi ed 
by cutting the PCR product using Apo1 restriction enzymes to produce 100bp and 34bp fragments.
Results: Forty six samples from P. falciparum-infected patients were collected from the two areas.The 
genes encoding the Pfcrt protein were succesfully amplifi ed, all 46 PCR products showed 100bp and 34bp 
fragments after incubation with Apo1 restriction enzyme. It indicated that pfcrt polymorphism was 100%.
Conclusion: The frequency of pfcrt gene polymorphisms in patients with malaria falciparum in Bandar 
Lampung and Lampung Selatan was 100%.
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INTISARI
Pendahuluan: Prevalensi malaria di Provinsi Lampung meningkat dalam beberapa tahun terakhir. Salah 
satu faktor yang berperan pada peningkatan angka ini ialah tersebar luasnya Plasmodium falciparum 
yang resisten terhadap obat malaria. Mutasi gen pengkode protein Pfcrt dilaporkan berkorelasi dengan 
resistensi ini.
Tujuan: Untuk mendapatkan frekuensi dan distribusi polimorfi sme gen pfcrt di antara Plasmodium 
falciparum pada pasien malaria di daerah endemik di Bandar Lampung dan Lampung Selatan, Provinsi 
Lampung.
Metode: Sampel darah dikumpulkan dari pasien malaria falciparum di Bandar Lampung dan Lampung 
Selatan dengan deteksi kasus secara aktif dan pasif. Darah vena sebanyak 2 sampai 3 mL dikumpulkan 
dalam tabung EDTA dan disimpan pada suhu -200C sebelum ekstraksi DNA. DNA dari masing-masing 
sampel diekstraksi memakai metode Guanidine isothiocyanate and Chelex 100. Gen pengkode protein 
Pfcrt diamplifi kasi dengan Nested PCR memakai primer TCRP dan TCRD. Polimorfi sme gen pfcrt diidentifi kasi 
dengan memotong produk PCR memakai enzim restriksi Apo1 untuk menghasilkan fragmen 100bp dan 
34bp. 
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INTRODUCTION
Lampung Province is an endemic area with 
a potential for the development of malaria, 
particularly in rural areas which have swamps, 
pools of brackish water at the seaside, and 
neglected fish ponds, except several areas in 
Kabupaten Lampung Barat which consists of 
paddyfields and farms. In Lampung Province, 
two of the malaria endemic areas are Kotamadya 
Bandar Lampung and Kabupaten Lampung 
Selatan. Annual Malaria Infection (AMI) or 
incidence rate of malaria in Kotamadya Bandar 
Lampung in 2007 was 12.86, while in Lampung 
Selatan,it was 8.51.1It showed the high rate of 
malaria incidence in this area.
The increase of malaria incidence is caused 
by several factors, one of them is malaria 
cases which are resistant to antimalarial drugs. 
Resistance of malaria parasite to chloroquine 
was initially emerged in Thailand in 1961 and in 
USA in 1962. Chloroquine-resistant malaria cases 
have been found in all provinces in Indonesia, 
including Lampung.2Fidock et al.3reported that 
pfcrt gene polymorphism was closely related to 
P. falciparum resistance to the chloroquine.
In Indonesia, there are only a few studies 
on pfcrt gene polymorphism related to the 
chloroquine resistance. Lampung Province, as one 
of the endemic areas of malaria, has not reported 
the presence of pfcrt gene polymorphism. The 
aim of this research was to identify the pfcrt gene 
polymorphism in malaria falciparum patients in 
Kotamadya Bandar Lampung and Kabupaten 
Lampung Selatan.
Research on polymorphism in pfcrt gene of 
P. falciparum resistant to chloroquine has been 
reported by several author such as Basco & 
Ringwald4 on isolates from Cameroon, Babiker 
et al.5 on isolates from Sudan, Dorsey et al.6 
on isolates from Uganda, Thomas et al.7 on 
isolates from Senegal, Basco8 on isolates from 
Cameroon, Lim et al.9 on isolates from Cambodia, 
and Happiet al.10 on isolates from Nigeria. Yearly 
malaria incidence rate in Kotamadya Bandar 
Lampung and Kabupaten Lampung Selatan is 
still high, despite treatment with ACT. A study 
was conducted to find out the pfcrt gene 
polymorphism, frequency and distribution of 
gene polymorphism, and factors associated with 
incidence of pfcrt gene polymorphism obtained 
from malaria patients in malaria endemic area 
in Kotamadya Bandar Lampung and Kabupaten 
Lampung Selatan.
MATERIALS AND METHODS
It was an analytical descriptive study with 
cross-sectional design on 46 samples, which 
consisted of 29 samples from Bandar Lampung 
and 17 samples from Lampung Selatan. Case 
subjects had to satisfy the inclusion criteria and 
willing to become subjects of the study.
The pfcrt gene polymorphism was determined 
with nested Polymerase Chain Reaction 
(PCR) method using 2 pairs of TCRP and TCRD 
primers. Primers for first nested PCR wereTCRP1 
(5’CCGTTAATAATAAATACACG CAG3’) as reverse 
primer and TCRP2 (5’CGGATGTTACAAAACTAT 
AGTTAC3’) as forward primer. PCR condition in 
the first nested PCR used denaturation at the 
TMJ • Vol. 01 • No.01 • 47-53
Hasil: Empat puluh enam sampel dari pasien terinfeksi P. falciparum dikumpulkan dari 2 daerah. Gen 
pengkode protein Pfcrt berhasil diamplifi kasi. Semua produk PCR menunjukkan fragmen 100bp dan 34bp 
setelah inkubasi dengan enzim restriksi Apo1. Hal ini menunjukkan bahwa polimorfi sme pfcrt 100%.
Simpulan: Frekuensi polimorfi sme gen pfcrt pada pasien dengan malaria falciparum di Bandar Lampung 
dan Lampung Selatan 100%. 
Kata kunci: malaria falciparum, pfcrt, klorokuin, polimorfi sme
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Figure 1. Electrophoresis of PCR product pfcrt gene from malaria falciparum patients. Column 1 was 
DNA marker, column 2 was positive control and column 3-17 were samples no 1-15.
Figure 2. RFLP Electrophoresis patern on the pfcrt gene which was cleavaged by Apo1  restriction 
enzyme on agarose gel 2%. Column 1-8 were patient samples No. 1-8. Column 9 was DNA 
marker. Column 10-17 were patients No. 9-16.
temperature of 94°C for 3 minutes, annealing 
at the temperature of 56°C for 30 seconds, and 
extension at the temperature of 60°C for 1 minute. 
At the next cycle until the 45th cycle, the duration 
of denaturation was shortened to 30 seconds 
without changing other conditions. At the last 
extension phase, the duration was prolonged 
for 3 minutes. Primer for the second nested PCR 
was TCRD1 (5’TGTGCTCATGTGTTTAAACTT3’)
as reverse primer dan TCRD2 
(5’CAAAACTATAGTTACCAATTTTG3’) as forward 
primer. PCR sequence for the second nested PCR 
used denaturation at the temperature of 95°C for 
5 minutes, annealing at the temperature of 48°C 
for 30 seconds, and extension at the temperature 
of 650°C for 30 seconds. At the next cycle until 
the 30th cycle, the duration of denaturation 
was shortened to 30 seconds without changing 
other conditions. At the last extension phase, 
the duration was prolonged for 3 minutes.
Electrophoresis of the PCR product on agarose 
gel 2% stained with ethidium bromide was 
conducted, and the visualization was observed 
with UV transilluminator. Second PCR product 
was cleaved with Apo1 restriction enzyme.4
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RESULTS AND DISCUSSION
Result of DNA isolation was amplified 
with nested PCR method. Result of first stage 
amplification was single DNA band with the size 
of 537 bp. Product of the first nested PCR was 
reamplified and the result was single DNA band 
in the size of 134 bp.
The Result showed that pfcrt gene on all 
samples were cleavaged by Apo1 restriction 
enzyme, indicated polymorphism.
Mechanism of resistance may be affected by 
genetic factor. There are several genes encoding 
the resistance to chloroquine. Omar et al.11 
stated that mutation on gene in chromosome V 
encoding food vacuole membrane protein, which 
referred as P-glycoprotein homolog-1 (Pgh-1), 
was considered to have role in the mechanism 
of P. falciparum resistance to chloroquine. This 
membrane protein is homologue to membrane 
protein in mamalia cancer cells resistant to 
anticancer treatments (multidrug resistance).12 
This gene is called P. falciparum multidrug 
resistance (pfmdr1). However, several studies 
in the field at different locations gave different 
results, both in vivo and in vitro. Besides, analysis 
with genetic cross technique on both genes did 
not show relationship with resistance process.
Study by Fidock et al.3 found single gene 
with the length of 36 kb in choromosome 7. This 
gene was referred as Plasmodium falciparum 
chloroquine resistance transporter (pfcrt). This 
gene encodes protein which consists of 424 
amino acids. Protein with mass of 48.6 kDa 
had 10 transmembrane segments located on 
food vacuole membrane of P. Falciparum, and 
functions as chloroquine transporter to food 
vacuole. In normal condition, mechanism of 
action of chloroquine in food vacuoles is to 
prevent the polymerization reaction, so that the 
heme is not detoxified. Ferriprotoporphyrin IX in 
the heme, or when it is bound to chloroquine, 
will form a complex molecule which is toxic to 
cells, and at specific concentration may lyse the 
parasite membrane. It is because chloroquine-
ferriprotoporphyrin IX complex disrupts 
the permeablity of parasite membrane and 
membrane proton pump. Besides, chloroquine, or 
together with chloroquine-ferriprotoporphyrin IX 
complex, may increase the pH in food vacuoles, 
which causes disruption of metabolism in food 
vacuoles, results in the death of the parasite.
In chloroquine-resistant P. Falciparum, there 
is no inhibition to polymerization reaction. It 
is assumed to be related to genetic mutation. 
Several genes are assumed to be included in the 
mechanism of resistance are pfmdr-1 and cg2, 
but from previous study, the association of these 
genes was not significant. Mutation of pfcrt 
protein will increase the affinity to CQH+, which 
results in the increase in excretion of most CQH+ 
from food vacuoles, so that the polymerization 
process may proceed normally. Simultaneously, 
pfcrt protein mutation results in the decrease in 
affinity to AAH+, which in turn causes a decrease 
in the excretion of AAH+ and increase the total 
proton in food vacuoles.13
A study in Sudan showed mutation in all 
codons, except codon 76 from pfcrt gene which 
showed fenotype of chloroquine-sensitive P. 
falciparum, and vice versa, if  there is a mutation 
on codon 76 with or without any mutations 
on other codons, it will result in fenotype of 
chloroquine-resistant P. falciparum.5 In other 
study, found alternative mutation as variation 
to codon 76 from resistant strain, that is, 
K76T, K76N, and K76I, so that it may be said 
that the change in amino acid lysine in codon 
76 is the key which holds an important role in 
the mechanism of resistance.9 Furhermore, 
Djimde et al.14 suggested that this mutation may 
become marker for resistance of P. falciparum to 
chloroquine.
In this study, all patients of malaria falciparum 
had polymorphism in pfcrt gene (100%). 
Several studies showed significant association 
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between pfcrt gene polymorphism and failure 
in treatment. All patients who fail (resistant) in 
treatment had parasites which had mutation 
in pfcrt gene (100%).14,15 From data above, it 
was known that Kotamadya Bandar Lampung 
and Kabupaten Lampung Selatan had high rate 
of treatment failure because of resistance to 
antimalarial drugs. 
One of the causes of pfcrt gene polymorphism 
was chloroquine that has been used as 
antimalaria for more than 40 years. In Lampung, 
in 2003 it has been reported that the resistance 
to chloroquine was 57.5%.15 Aside from genetic 
mechanism associated with gene polymorphism, 
failure of chloroquine in eliminating malaria 
parasite may be explained by other mecahnism. 
Malaria parasite synthesize its amino acid by 
degrading hemoglobin into heme, which contain 
ferriprotoporphyrin IX which is toxic to parasites. 
Normally, heme will be polymerized by parasites 
into non-toxic hemozoin. Chloroquine in food 
vacuoles will be bound to protoporphyrin IX and 
forms complex molecule bond which is toxic to 
the parasite.16
The decrease in chloroquine accumulation 
in food vacuoles of parasites will result in 
inadequate concentration to prevent heme 
polymerization reaction into hemozoin. This 
will result in normal detoxification process of 
ferriprotoporphyrin IX, and parasites will survive. 
Accumulation process of chloroquine includes 
proton pump and facilitated by specific receptor 
in food vacuole.17 In resistant Plasmodium, it 
is assumed that parasites have no receptor to 
bind chloroquine, so that this drug can not be 
accumulated in parasite food vacuoles.18
In Indonesia, chloroquine has been used as 
antimalarial drug in malaria eradication program 
since 1959. The use of therapeutic dose of 
chloroquine in prolonged duration and repeated 
doses by the population will cause drug pressure, 
which will be followed by resistant parasite.19,20 
The use of inadequate or low doses did not kill 
parasites. The use of low dose in prolonged 
period will cause the parasites to be tolerant 
to antimalarial drugs, so that there will be 
spontanoeus mutation selection from parasite 
genetic composition, which will cause resistance 
to antimalarial drugs.19
Treatment monitoring of malaria patients 
and treatment follow-up in Puskesmas/Primary 
Health Center (PHC) or Puskesmas Pembantu/
Supporting PHC have not been conducted 
according to the rule, so that early detection 
on resistance cases to antimalarial drugs from 
old or repeated visits of malaria patients has 
not been conducted well. This is aggravated by 
the lack of decentralization of sensitivity test to 
antimalarial drugs in PHC.21  Inappropriate drug 
taking method, so that drug dose in the blood do 
not achieve the expected dose, may accelerate 
the emergence of resistance to chloroquine. 
Tolerant parasites to antimalarial drugs will lead 
to genetic mutation selection, which will be 
resistant to the drugs.22
CONCLUSIONS
Based on the result could be concluded 
that the frequency of pfcrt gene polymorphism 
was 100%, which spread in Kotamadya Bandar 
Lampung and Kabupaten Lampung Selatan. 
However, factors associated with the distribution 
of pfcrt gene polymorphism in Kotamadya Bandar 
Lampung and Kabupaten Lampung Selatan 
could not be analyzed because the frequency of 
polymorphism was 100%.
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